Trial intelligence / Profile preview

Haplo-SCT16 for relapsed or refractory childhood acute leukemia

jRCTs041190061Active, not recruiting

Sponsor
Kaneka
Start
Oct 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of antithymocyte globulin rabbit, tacrolimus, methotrexate and prednisolone in Acute Leukaemia, sponsored by Kaneka. Primary endpoint: 2-year event-free survival. Started Oct 2019; status: active, not recruiting.

02

Drugs

antithymocyte globulin rabbittacrolimusmethotrexateprednisolone
03

Conditions

Acute Leukaemia

Beyond the preview

Go deeper on jRCTs041190061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041190061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call